EVO
Evotec SE
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · DE
$1.86
−2.11%Leverage
- Debt / equity
- 0.71x
- Net debt / equity
- 0.19x
- Debt / assets
- 0.30x
- Debt / EBITDA
- -5.56x
- Net debt / EBITDA
- -1.49x
Liquidity & coverage
- Current ratio
- 2.33x
- Quick ratio
- 2.21x
- Cash ratio
- 1.49x
- Interest coverage
- -11.05x
- EBITDA / interest
- -7.35x
- Working capital
- $484.1M
Cash & dividend
- FCF / debt
- -0.35x
- Cash flow / debt
- -0.25x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -6.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026